A period of complacency and a lack of focus on potential pandemics has meant that documented shortages of personnel, workforce and equipment has limited healthcare delivery.
After testing Los Angeles County residents for antibodies to the new coronavirus, researchers with USC and the department of public health calculated that many more individuals in L.A. County had SARS-CoV-2 antibodies than previously thought.
The unprecedented impact of COVID‐19 has generated feelings of fear, grief and helplessness for people around the world and for many health professionals these emotions are particularly accentuated.
Schaeffer Initiative researchers quantify the estimated costs of COVID-19 care in the U.S. in a new report.
Once a COVID-19 vaccine is developed, achieving universal immunization will require a cohesive, multi-faceted vaccination strategy across the U.S. healthcare system.
To reopen safely, employers need to identify workers who have active COVID-19 infections and do so at reasonable cost. Pooled testing for the coronavirus is an effective, scalable tool for doing so.
One-in-twelve episodes at ambulatory surgery centers had the potential to result in a surprise medical bill, according to the study.
Auto-enrollment into health insurance coverage is an attractive policy that can drive the U.S. health care system towards universal coverage.
The speed and extent of biosimilar penetration differ across provider types. Provider awareness and incentives are significantly associated with biosimilar uptake.
If cost-sharing were based on net price it would provide meaningful financial relief to many Part D beneficiaries.